Solutions to Improve Access to Medicines and Biomedical Innovation Through EU Trade and R&D Policy
[Médecins Sans Frontières Access Campaign] The European Union’s (EU) free trade and research and development (R&D) policies promote excessive intellectual property (IP) protection. This approach jeopardises access to affordable, needed medicines and impedes needs-driven biomedical innovation. Médecins Sans Frontières Access…
